LOGICBIO

Serial Number 88813195
Registration 6654329
700

Registration Progress

Application Filed
Feb 27, 2020
Under Examination
Aug 25, 2020
Approved for Publication
Jun 30, 2020
Published for Opposition
Jun 30, 2020
Registered
Feb 22, 2022

Trademark Image

LOGICBIO

Basic Information

Serial Number
88813195
Registration Number
6654329
Filing Date
February 27, 2020
Registration Date
February 22, 2022
Published for Opposition
June 30, 2020
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
Feb 22, 2022
Registration
Registered
Classes
005 042

Rights Holder

LogicBio Therapeutics, Inc.

03
Address
65 Hayden Ave
Lexington, MA 02421

Ownership History

LogicBio Therapeutics, Inc.

Original Applicant
03
Cambridge, MA

LogicBio Therapeutics, Inc.

Owner at Publication
03
Lexington, MA

LogicBio Therapeutics, Inc.

Original Registrant
03
Lexington, MA

Legal Representation

Attorney
Cara M. Kearney

USPTO Deadlines

Next Deadline
782 days remaining
Section 8 Declaration Due (Principal Register) (Based on registration date 20220222)
Due Date
February 22, 2028
Grace Period Ends
August 22, 2028
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

36 events
Date Code Type Description Documents
Mar 18, 2025 EWAF I TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS Loading...
Mar 18, 2025 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Mar 18, 2025 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Mar 18, 2025 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Apr 11, 2024 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Apr 11, 2024 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Apr 11, 2024 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Aug 3, 2023 EWAF I TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS Loading...
Aug 3, 2023 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Aug 3, 2023 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Aug 3, 2023 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Aug 3, 2023 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
Aug 3, 2023 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED Loading...
Feb 22, 2022 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Jan 18, 2022 SUNA E NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED Loading...
Jan 17, 2022 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Loading...
Jan 7, 2022 SUPC I STATEMENT OF USE PROCESSING COMPLETE Loading...
Dec 15, 2021 IUAF S USE AMENDMENT FILED Loading...
Jan 7, 2022 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Dec 15, 2021 EISU I TEAS STATEMENT OF USE RECEIVED Loading...
Jul 1, 2021 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jun 29, 2021 EX2G S SOU EXTENSION 2 GRANTED Loading...
Jun 29, 2021 EXT2 S SOU EXTENSION 2 FILED Loading...
Jun 29, 2021 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Feb 16, 2021 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Feb 12, 2021 EX1G S SOU EXTENSION 1 GRANTED Loading...
Feb 12, 2021 EXT1 S SOU EXTENSION 1 FILED Loading...
Feb 12, 2021 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Aug 25, 2020 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Jun 30, 2020 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Jun 30, 2020 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jun 10, 2020 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
May 22, 2020 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
May 18, 2020 DOCK D ASSIGNED TO EXAMINER Loading...
Mar 9, 2020 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Mar 5, 2020 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations for gene therapy and gene editing
First Use Anywhere: May 26, 2021
First Use in Commerce: May 26, 2021
Class 042
Testing, inspection, research, and development of pharmaceutical preparations for gene therapy and gene editing; medical and scientific research in the fields of gene therapy and gene editing; pharmaceutical research services; pharmaceutical drug development services
First Use Anywhere: Oct 26, 2021
First Use in Commerce: Oct 26, 2021

Additional Information

Pseudo Mark
LOGIC BIO

Classification

International Classes
005 042